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Abstract
Objectives: To identify opportunities for reducing emergency colon cancer diagno‐
ses,	we	evaluated	symptoms	and	benign	diagnoses	recorded	before	emergency	pres‐
entations	(EP).
Methods: Cohort	of	5,745	colon	cancers	diagnosed	in	England	2005–2010,	with	in‐
dividually linked cancer registry and primary care data for the 5‐year pre‐diagnostic 
period.
Results: Colon	cancer	was	diagnosed	following	EP	in	34%	of	women	and	30%	of	men.	
Among	emergency	presenters,	20%	of	women	and	15%	of	men	(p	=	0.002)	had	alarm	
symptoms	(anaemia/rectal	bleeding/change	in	bowel	habit)	2–12	months	pre‐diagno‐
sis.	 Women	 with	 abdominal	 symptoms	 (change	 in	 bowel	 habit/constipation/diar‐
rhoea)	 received	 a	 benign	 diagnosis	 (irritable	 bowel	 syndrome	 (IBS)/diverticular	
disease)	more	frequently	than	men	in	the	year	before	EP:	12%	vs.	6%	among	women	
and	men	(p	=	0.002).	EP	was	more	likely	in	women	(OR	=	1.20;	95%	CI	1.1–1.4),	inde‐
pendently	of	socio‐demographic	factors	and	symptoms.	Benign	diagnoses	in	the	pre‐
diagnostic	 year	 (OR	=	2.01;	 95%	CI	 1.2–3.3)	 and	 anaemia	 2–5	years	 pre‐diagnosis	
(OR	=	1.91;	95%	CI	1.2–3.0)	increased	the	risk	of	EP	in	women	but	not	men.	The	risk	
was	particularly	high	for	women	aged	40–59	with	a	recent	benign	diagnosis	vs.	none	
(OR	=	4.41;	95%	CI	1.3–14.9).
Conclusions: Women	have	an	increased	risk	of	EP,	in	part	due	to	less	specific	symp‐
toms	 and	 their	 more	 frequent	 attribution	 to	 benign	 diagnoses.	 For	 women	 aged	
40–59	years	with	 new‐onset	 IBS/diverticular	 disease	 innovative	 diagnostic	 strate‐
gies	are	needed,	which	might	include	use	of	quantitative	faecal	haemoglobin	testing	
(FIT)	or	other	colorectal	cancer	investigations.	One‐fifth	of	women	had	alarm	symp‐
toms	before	EP,	offering	opportunities	for	earlier	diagnosis.
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1  | INTRODUCTION
Internationally,	 emergency	 colorectal	 cancer	 diagnoses	 range	 be‐
tween	14%	and	33%	(Zhou	et	al.,	2017),	with	only	few	studies	pro‐
viding	 separate	 figures	 for	 colon	 and	 rectal	 cancers,	 despite	 the	
much higher risk of emergency presentations among colon cancers 
(31%	vs.	15%	for	colon	and	rectal	cancers;	Abel,	Shelton,	Johnson,	
Elliss‐Brookes,	&	Lyratzopoulos,	2015).	In	the	United	Kingdom,	one	
in	three	colon	cancers	are	diagnosed	as	an	emergency	(Zhou	et	al.,	
2017).	Reducing	emergency	presentations	is	 important	as	they	are	
associated	with	worse	12‐month	 cancer	 survival	 (51%	after	 emer‐
gency	 vs.	 more	 than	 80%	 after	 non‐emergency	 colorectal	 cancer	
diagnosis;	NCIN).	Women,	 older	 and	 deprived	 individuals	 have	 an	
increased	risk	of	emergency	presentations	(Abel	et	al.,	2015;	Renzi,	
Lyratzopoulos	et	al.,	2016;	Wallace	et	al.,	2014;	Zhou	et	al.,	2017),	
with	 the	 risk	 for	 women	 vs.	 men	 ranging	 between	 OR	=	1.2	 and	
1.4	 (p	<	0.05;	Abel	 et	 al.,	 2015;	 Renzi,	 Lyratzopoulos	 et	 al.,	 2016).	
Women	with	colon	cancer	have	lower	12‐month	survival	than	men,	
both	overall	(Quaresma,	Coleman,	&	Rachet,	2015)	and	across	spe‐
cific	 diagnostic	 routes,	 with	 women	 diagnosed	 after	 emergency	
presentation	having	particularly	 low	survival	 (NCIN).	However,	ev‐
idence on the circumstances surrounding emergency presentations 
and on reasons for the higher risk of emergency diagnoses among 
women is scant.
Patient,	 health	 care	 and	 tumour	 factors	 are	 possible	 expla‐
nations	 (Zhou	 et	 al.,	 2017),	 including	 less	 frequent	 help‐seeking	
among	some	subgroups	due	to	cancer	fear,	fatalism	or	poor	cancer	
awareness	 (Robb	et	al.,	2009),	as	well	as	delays	 in	 investigations	
or	 diagnostic	 difficulties	 due	 to	 comorbidities,	 benign	 diagnoses	
and atypical presentations. Risk factors might differ for men and 
women:	 for	 example,	 proximal	 cancers	occur	more	 frequently	 in	
women,	possibly	leading	to	gender	differences	in	diagnostic	com‐
plexity,	as	proximal	cancers	often	present	with	non‐specific	symp‐
toms	and	are	beyond	the	reach	of	flexible	sigmoidoscopy	(Holme	
et	 al.,	 2017).	 Generally,	 women	 are	more	 frequent	 help	 seekers	
(Hansen,	Hjertholm,	&	Vedsted,	 2015),	 but	 no	 population‐based	
evidence	exists	 on	patterns	of	 symptomatic	 presentation	during	
the months and years before a cancer diagnosis by gender and 
how this might impact on emergency diagnoses.
Diagnostic	pathways	might	also	be	influenced	by	previous	diag‐
noses	of	benign	conditions	(Renzi,	Whitaker,	Winstanley,	Cromme,	&	
Wardle,	2016),	such	as	irritable	bowel	syndrome	(IBS)	or	diverticular	
disease,	which	can	present	with	overlapping	symptomatology	with	
colon	 cancer	 (Regula,	 2016),	 complicating	 symptom	 interpretation	
and	differential	diagnosis.	Diagnostic	difficulties	might	be	particu‐
larly	relevant	in	women,	who	have	a	higher	prevalence	of	IBS	com‐
pared	with	men	(Lovell	&	Ford,	2012;	Sperber	et	al.,	2017).	Overall,	
the	incidence	of	colorectal	cancer	in	patients	diagnosed	with	IBS	or	
diverticular	 disease	 is	 similar	 to	 the	 general	 population	 (Canavan,	
Card,	&	West,	2014;	Norgaard	et	al.,	2011;	Regula,	2016).	However,	
in	 the	months	 immediately	 after	 the	 benign	 diagnosis,	 there	 is	 an	
increased	risk	of	colon	cancer	(Canavan	et	al.,	2014;	Norgaard	et	al.,	
2011;	Regula,	2016),	especially	among	individuals	aged	<50	(Canavan	
et	al.,	2014).	It	is	unknown	whether	colon	cancer	patients	receiving	
a	diagnosis	of	IBS	or	diverticular	disease	are	at	increased	risk	of	an	
emergency rather than non‐emergency cancer diagnosis.
The present study is part of a wider project on emergency pre‐
sentations	based	on	 linked	cancer	registry,	primary	and	secondary	
care	 data	 (Renzi,	 Lyratzopoulos	 et	 al.,	 2016).	We	 have	 previously	
shown that consultations increase markedly during the pre‐diagnos‐
tic	year,	independently	of	diagnostic	route,	with	emergency	present‐
ers	having	less	frequently	typical	alarm	symptoms.
This study aimed to take the previous work further and increase 
our understanding on reasons for the higher risk of emergency pre‐
sentations	among	women,	in	order	to	identify	possible	opportunities	
for earlier diagnosis overall and in women in particular. We focused 
on	consultation	patterns,	signs/symptoms	and	benign	diagnoses	re‐
corded	before	the	colon	cancer	diagnosis,	comparing	emergency	and	
non‐emergency	presenters	by	gender,	 taking	cancer	 sub‐sites	 into	
account.	As	almost	half	of	colon	cancers	occur	in	women,	reducing	
their risk of emergency presentations can be beneficial not only for 
the	affected	individual	but	also	more	generally	for	public	health,	in	
terms of overall cancer survival and reduced disruptions to hospital 
services.
2  | METHODS
2.1 | Study population and data sources
The present cohort study focused on patients with an incident 
colon	cancer	 (ICD10	codes	C18)	diagnosed	 in	England	2005–2010	
recorded in the National Cancer Registry and individually linked 
to	 primary	 care	 data	 (provided	 by	 the	 Clinical	 Practice	 Research	
Datalink‐	 CPRD)	 and	 secondary	 care	 data	 (Hospital	 Episode	
Statistics‐HES).	 About	 6.9%	 of	 the	 UK	 population	 is	 covered	 by	
CPRD	 and	 included	 patients	 are	 considered	 to	 be	 representative	
of	the	general	UK	population	(Herrett	et	al.,	2015).	We	focused	on	
colon	cancer,	rather	than	colorectal,	given	the	particularly	high	risk	
of emergency presentations.
Inclusion	 criteria	were:	 ages	18	years	or	over	 at	 cancer	diag‐
nosis,	no	previous	cancer	at	any	site	and	having	at	least	1	year	of	
primary	care	CPRD	records	prior	to	cancer	diagnosis.	We	excluded	
records	not	meeting	 the	CPRD	quality	 criteria	 (e.g.,	 “up‐to‐stan‐
dard”	date).	Patients	with	previous	cancers	were	excluded	as	their	
consultation and referral patterns are likely to be different from 
patients	with	no	cancer	history	(due	to	higher	cancer	awareness,	
regular	follow‐up	visits,	and	lower	threshold	for	referrals/investi‐
gations).	As	expected,	6.5%	of	colon	cancers	from	the	cancer	reg‐
istry	were	successfully	linked	to	active	and	up‐to‐standard	CPRD	
records	 (N	=	6,316	 patients	 out	 of	 97,937	 incident	 colon	 can‐
cers	 diagnosed	 in	 2005–2010;	 details	 in	 Supporting	 Information	
Appendix	Figure	S1).	After	excluding	patients	with	missing	socio‐
demographic	 or	 route	 to	 diagnosis	 information,	 a	 total	 of	 5,745	
individuals were included.
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The	 following	 ethics	 approval	 was	 obtained:	 ISAC‐Protocol	
08_031R;	NHS	Health	Research	Authority	Confidentiality	Advisory	
Group	(PIAG	1‐05(c)/2007).
Further	details	on	the	overall	project	have	been	previously	pub‐
lished	(Renzi,	Lyratzopoulos	et	al.,	2016).
2.2 | Study variables
The	 outcome	 of	 interest	 was	 emergency	 diagnosis,	 defined	 as	 a	
colon	 cancer	 diagnosed	 following	 presentation	 to	 Accident	 and	
Emergency,	 GP	 emergency	 referrals	 or	 emergency	 pathways	 for	
in/out‐patients,	 according	 to	 the	 Routes	 to	 Diagnosis	 algorithm	
(Elliss‐Brookes	et	al.,	2012;	NCIN).	Accident	and	Emergency	and	GP	
emergency	referrals	account	for	90%	of	emergency	diagnoses	and	
are	characterised	by	similar	1‐year	survival	(NCIN).	Non‐emergency	
diagnoses	included	routine	GP	referrals,	2‐week	wait	referral,	inpa‐
tient/outpatient elective and screening.
The	 main	 explanatory	 variables	 were	 signs/symptoms	 recorded	
before	the	cancer	diagnosis.	CPRD	provides	patient‐level	information	
recorded prospectively in primary care on type and timing of signs/
symptoms,	 test	 results	 (e.g.,	 iron‐deficiency	 anaemia)	 and	 referrals.	
Based	on	the	literature	and	guidelines	(Din	et	al.,	2015;	NICE	Guidelines	
[NG12];	Sheringham,	Georghiou,	Chitnis,	&	Bardsley,	2014),	we	opera‐
tionally defined relevant signs/symptoms that could prompt diagnostic 
work‐up	for	a	possible	colon	cancer.	Clinical	experts	reviewed	the	list	
and	Medcodes/Readcodes	for	relevant	symptoms	(e.g.,	 rectal	bleed‐
ing,	 change	 in	 bowel	 habit,	 anaemia)	were	 identified	 and	 applied	 to	
CPRD	records	(code‐list	in	AppendixS1).	Clinical	experts	included	GPs,	
gastroenterologist and public health specialists with a specific interest 
in	cancer	and	expertise	in	using	CPRD.	In	addition,	colorectal	cancer	
patients have taken part in discussing relevant signs/symptoms.
The analysis focused on primary care records referring to the 
pre‐diagnostic	 year,	 but	 earlier	 records,	 up	 to	 5	years	 pre‐diagno‐
sis,	were	used	to	examine	frequency	of	GP	consultations	over	time	
and	to	categorise	each	sign/symptom	as	“new”	(a	symptom	recorded	
for	 the	 first	 time	during	 the	pre‐diagnostic	 year,	with	no	prior	 re‐
cord	of	 the	same	symptom),	 “chronic”	 (recorded	during	the	pre‐di‐
agnostic	year	and	at	least	once	in	previous	months/years)	and	“past”	
(recorded	only	 in	 the	past	2–5	years,	with	no	record	 in	 the	pre‐di‐
agnostic	year).	We	developed	this	classification	as	we	hypothesised	
that the effect on emergency presentation might be influenced by 
the	timing	of	symptom	onset	and	past	symptom	experience.
Further	explanatory	variables	were	benign	intestinal	conditions	
(irritable	 bowel	 syndrome	 (IBS),	 diverticular	 disease	 and	 haemor‐
rhoids)	 recorded	 in	 primary	 care	 before	 the	 cancer	 diagnosis.	We	
grouped	 IBS	and	diverticular	disease	 together	due	 to	 sparse	data.	
These two conditions also have many overlapping features and often 
present	with	recurrent	abdominal	symptoms	(Strate,	Modi,	Cohen,	&	
Spiegel,	2012).
Relevant referrals for a gastro‐intestinal consultation and/or inves‐
tigations	(lower	GI	endoscopies,	imaging	of	digestive	tract,	abdominal	
ultrasound	scan,	CT/MRI)	recorded	in	CPRD	during	the	pre‐diagnostic	
year	were	also	examined.	A	binary	variable	(any	relevant	referral	vs.	
none)	was	created.	Small	numbers	prevented	us	from	analysing	spe‐
cific	referrals	separately.	In	line	with	previous	studies,	we	used	three	
or	more	GP	consultations	with	relevant	symptoms	as	a	proxy	for	re‐
ferral	delays	(Lyratzopoulos,	Neal,	Barbiere,	Rubin,	&	Abel,	2012).
We	identified	comorbidities	recorded	in	HES	using	a	previously	
developed	algorithm	(Maringe,	Fowler,	Rachet,	&	Luque‐Fernandez,	
2017;	 Shack,	 Rachet,	 Williams,	 Northover,	 &	 Coleman,	 2010).	 As	
linked	 HES	 records	 were	 available	 from	 2003	 onwards,	 a	 2‐year	
pre‐diagnostic	time	window	was	chosen,	in	order	to	have	the	same	
secondary	care	observation	period	for	all	patients,	 including	those	
diagnosed with cancer in 2005.
Cancer	 sub‐sites	 were	 classified	 into	 distal	 (left)	 colon	 (i.e.,	
splenic	flexure,	descending	colon,	sigmoid	colon;	ICD	C18.5–C18.7)	
and	proximal	(right)	colon	(i.e.,	caecum,	appendix,	ascending	colon,	
hepatic	 flexure,	 transverse;	 C18.0–C18.4)	 (Doubeni	 et	 al.,	 2016;	
Hansen	et	al.,	2015;	Karim,	Brennan,	Nanji,	Berry,	&	Booth,	2017).
Socio‐demographic	 characteristics	 included	 gender,	 age	 and	
deprivation	based	on	 the	 income	domain	of	 the	 Index	of	Multiple	
Deprivation	for	England.
2.3 | Statistical analysis
We first described socio‐demographic characteristics and pre‐di‐
agnostic	 signs/symptoms,	 benign	 diagnoses	 and	 comorbidities	
comparing emergency vs. non‐emergency presenters. Men and 
women	were	 examined	 separately	 throughout.	 In	 line	with	 previ‐
ous	research	(Guldbrandt,	Moller,	Jakobsen,	&	Vedsted,	2017;	Renzi,	
Lyratzopoulos	et	al.,	2016;	Sheringham	et	al.,	2014),	when	analysing	
events	occurring	in	the	pre‐diagnostic	year	we	excluded	the	30	days	
pre‐diagnosis,	as	events	occurring	shortly	before	diagnosis	might	be	
related	to	the	diagnostic	episode	itself,	rather	than	represent	oppor‐
tunities for earlier diagnosis.
We	 used	 Poisson	 regression	 to	 examine	 variations	 in	 consul‐
tation rates for relevant symptoms before the cancer diagnosis by 
gender,	age,	social	deprivation,	comorbidities	and	cancer	sub‐sites.	
Random effects were added to account for patient‐level clustering 
due to repeated symptomatic presentations. Consultation rates 
were	 divided	 into	 bi‐monthly	 and	 yearly	 time	 periods,	 in	 order	 to	
examine	variation	over	time.
Mixed‐effects	 multivariable	 logistic	 regression	 was	 used	 for	
examining	the	risk	of	emergency	presentations	according	to	socio‐
demographic	 characteristics,	 cancer	 sub‐site,	 number	 of	 consulta‐
tions	and	type	and	timing	of	sign/symptoms,	benign	diagnoses	and	
comorbidities. Random effects were added to account for clustering 
of	patients	by	GP	practice.	We	then	evaluated	 (a)	whether	 the	ef‐
fect for each sign/symptom and benign diagnoses varied for men 
and	women,	 and	 (b)	whether	 age	modified	 the	 effect	 of	 a	 benign	
diagnosis on the risk of emergency presentation.
Finally,	in	order	to	evaluate	whether	effects	vary	by	cancer	sub‐
site,	we	performed	multinomial	logistic	regression,	including	all	the	
previously mentioned variables into the model and comparing the 
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likelihood	of	emergency	diagnosis	separately	for	proximal	and	distal	
cancer compared to non‐emergency colon cancer diagnosis.
Statistical	 analyses	 were	 performed	 using	 STATA14	 software	
(Stata	Corporation,	College	Station,	TX,	USA).
3  | RESULTS
3.1 | Characteristics of the study cohort and 
prevalence of emergency cancer diagnosis
Among	 the	 5,745	 colon	 cancer	 patients	 included	 in	 the	 study,	
49%	were	women,	with	a	median	age	of	74	years	 (IQR	65–82)	 for	
women	 and	 72	 for	men	 (IQR	64–79).	Our	 cohort	 had	 comparable	
demographic characteristics to colon cancer patients in the National 
Cancer	Registry	unlinked	to	CPRD	(48%	women;	median	age	75	[IQR	
66–83]	 for	women	and	72	 for	men	 [IQR	64–80]).	Proximal	cancer	
was	 more	 frequent	 in	 women	 (53%	 vs.	 45%	 in	 men,	 p	<	0.001).	
Emergency	 presentations	 occurred	 in	 34%	of	women	 and	30%	of	
men,	with	higher	risks	for	people	from	more	deprived	areas	and	the	
oldest	 and	youngest	 age	groups	 (Table	1).	Distal	 cancers	were	as‐
sociated	with	a	lower	risk	of	emergency	presentation	than	proximal	
and unspecified colon sub‐sites.
3.2 | Consultation pattern before a colon cancer 
diagnosis by gender and cancer sub‐site
Consultation	 rates	 with	 relevant	 signs/symptoms	 (rectal	 bleed‐
ing,	 change	 in	 bowel	 habit,	 anaemia,	 abdominal	 pain,	 constipa‐
tion)	started	increasing	during	the	1–2	years	pre‐cancer	diagnosis,	
independently	 of	 gender,	 diagnostic	 route	 and	 cancer	 sub‐sites	
(Figure	1).	A	particularly	sharp	 increase	was	observed	 in	 the	pre‐
diagnostic	 year,	 with	 the	 important	 exception	 of	 women	 with	
TA B L E  1  Diagnosis	of	colon	cancer	after	Emergency	Presentation	(EP)	by	patients'	socio‐demographic	characteristics	and	cancer	sub‐site	
(N	=	5,745)
Women
p‐Valuea
Men
p‐Valuea
Non‐EP (%) EP (%) Total (N) Non‐EP (%) EP (%) Total (N)
N = 1859 N = 940 N = 2,799 N = 2072 N = 874 N = 2,946
Age	(years)
18–59 65.0 35.0 414 <0.001 68.0 32.0 431 <0.001
60–69 75.3 24.7 595 78.2 21.8 780
70–79 72.7 27.3 868 71.4 28.6 1,010
80+ 55.4 44.6 922 61.8 38.2 725
SES	(deprivation	quintile)
1	(least	deprived#) 70.4 29.6 609 0.005 71.5 28.5 708 0.057
2 66.3 33.7 602 69.9 30.1 654
3 66.4 33.6 601 73.7 26.3 574
4 65.9 34.1 513 68.2 31.8 529
5	(most	deprived) 58.3 41.7 350 65.2 34.8 353
Geographic	region
North 64.2 35.8 586 0.387 69.2 30.8 708 0.877
Midlands/East 
England
68.5 31.5 841 70.5 29.6 863
London 65.8 34.2 295 70.0 30.0 227
South 66.2 33.8 1,077 71.0 29.0 1,148
Year of CRC diagnosis
2005–2006 63.8 36.2 889 0.126 67.1 32.9 902 0.034
2007–2008 67.3 32.7 924 72.2 27.8 960
2009–2010 68.0 32.1 986 71.4 28.6 1,084
Cancer sub‐site
Colon	proximal 66.8 33.2 1,477 0.043 69.2 30.8 1,324 <0.001
Colon distal 67.8 32.2 1,010 73.8 26.2 1,329
Colon unspecified 60.3 39.7 312 59.7 40.3 293
Notes.	Distal	colon:	splenic	flexure,	descending	colon,	sigmoid	colon;	Proximal	colon:	transverse	and	ascending	colon.
aChi‐square	test	comparing	emergency	vs.	non‐emergency	presenters.	
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proximal	 cancer	 diagnosed	 as	 an	 emergency,	 whose	 increase	
started	 2	years	 pre‐diagnosis.	 Patients	with	 proximal	 cancer	 had	
higher	consultation	rates	than	those	with	distal	cancers,	with	con‐
sultations	increasing	earlier	for	emergency	presenters,	particularly	
among women.
Consultation rates with relevant symptoms were significantly 
higher	for	women	compared	to	men,	taking	age,	deprivation	and	can‐
cer	sub‐site	 into	account	(Supporting	Information	Appendix	Figure	
S2).	Consultation	rates	were	also	higher	for	older	patients	and	those	
in	more	deprived	areas,	while	distal	cancers	had	lower	consultation	
rates	compared	to	proximal	cancers.	Results	were	similar	repeating	
the analyses including also diagnostic route and comorbidity in the 
multivariable	model	(data	not	shown).
3.3 | Symptoms and benign diagnoses before 
emergency and non‐emergency presentation 
by gender
3.3.1 | Relevant symptoms
The proportion of patients with at least one consultation for rel‐
evant symptoms in the pre‐diagnostic year was higher among 
women	than	men	(60%	vs.	55%,	p	<	0.001),	with	women	also	having	
more	frequently	3	+	consultations	with	relevant	symptoms	(17%	vs.	
15%,	p	<	0.001;	Table	2).	Emergency	presenters	of	either	sex	had	
less	 frequently	 relevant	 symptoms	 compared	 to	 non‐emergency	
presenters.	However,	among	women	diagnosed	as	an	emergency,	
20%	 had	 alarm	 symptoms	 (anaemia,	 rectal	 bleeding,	 change	 in	
bowel	 habit)	 during	 the	 pre‐diagnostic	 year,	 vs.	 15%	among	men	
(p	=	0.002).
Past	anaemia	2–5	years	pre‐diagnosis	was	more	frequent	among	
emergency	 presenters,	 particularly	 for	 women.	 Anaemia,	 abdomi‐
nal	pain,	constipation	and	fatigue	were	more	frequently	recorded	in	
women than men.
3.3.2 | Benign diagnoses
Women	more	often	had	a	 record	of	a	benign	diagnosis	 (IBS/diver‐
ticular	disease)	in	the	pre‐diagnostic	year:	6%	vs.	2%	among	women	
and	men	diagnosed	as	an	emergency	(p	<	0.001)	(Table	2).	Similarly,	
in	 the	 subgroup	 of	 people	 with	 abdominal	 symptoms	 (change	 in	
bowel	 habit,	 abdominal	 pain,	 constipation	or	 diarrhoea,	n	=	2046),	
there was a greater probability of benign diagnoses during the pre‐
diagnostic	year	for	women	(9.5%)	vs.	men	(5.2%)	(p	<	0.001).	Further	
restricting this analysis to persons with abdominal symptoms who 
were	diagnosed	as	emergencies	 (n	=	574),	12.4%	of	women	vs.	6%	
of	men	received	a	benign	diagnosis	 (p	=	0.002)	 (data	not	shown	 in	
table).	This	gender	disparity	in	benign	diagnoses	was	also	observed	
when restricting the analysis to emergency presenters with alarm 
symptoms	(change	in	bowel	habit,	rectal	bleeding	or	anaemia):	9.5%	
vs.	2.4%	(p	=	0.01)	of	women	and	men	had	received	a	recent	benign	
diagnosis.
3.4 | Multivariable analysis examining factors 
associated with emergency presentation by 
gender and cancer sub‐site
At	 multivariable	 analysis,	 emergency	 presentations	 were	 more	
likely	 in	women	 (OR	=	1.20;	95%	CI	1.1–1.4),	as	well	as	among	the	
oldest	 and	 youngest	 age	 groups	 and	 the	most	 deprived,	 indepen‐
dently	 of	 symptoms,	 number	 of	 consultations	 and	 cancer	 sub‐site	
(Table	 3).	 Multiple	 pre‐referral	 consultations	 with	 relevant	 symp‐
toms	(OR	=	1.25;	95%	CI	1.1–1.6)	and	comorbidities	also	 increased	
the	risk	of	emergency	presentations,	while	new‐onset	alarm	symp‐
toms decreased the risk.
Among	 women,	 a	 recent	 benign	 diagnosis	 (OR	=	2.01;	 95%	
CI	 1.2–3.3)	 and	 a	 past	 history	 of	 anaemia	 2–5	years	 pre‐diagnosis	
(OR	=	1.91;	 95%	CI	 1.2–3.0)	 increased	 the	 risk	 of	 emergency	 pre‐
sentation	in	patients	with	distal	and	proximal	cancers,	respectively	
F I G U R E  1  Consultation	rates	with	relevant	symptoms	for	men	and	women	with	proximal	or	distal	colon	cancer	diagnosed	following	an	
emergency	presentation	(EP)	and	non‐emergency	presentation	(non‐EP).	Note:	Observed	data	points	and	fitted	local	polynomial	regression	
lines on logarithmic scale
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TA B L E  2  GP	consultations,	symptoms	and	benign	diagnoses	among	patients	diagnosed	with	colon	cancer	following	emergency	
presentation	(EP)	and	Non‐emergency	presentation	(non‐EP)
Women Men
Women  
vs. Men 
EP only
Women  vs. 
Men total 
sample
Non‐EP 
(%) EP (%) Total (%)
p‐
Valuea
Non‐EP (%) EP (%) Total (%)
p‐
Valuea p‐Valueb p‐ValuecN = 1859 N = 940 N = 2,799 N = 2072 N = 874 N = 2,946
No.	of	consultations	with	relevant	symptoms	between	2–12	months	pre‐diagnosis
0 
consultations
34.1 50.6 39.7 <0.001 39.8 57.6 45.0 <0.001 0.012 <0.001
1–2	
consultations
47.8 33.8 43.1 44.7 29.6 40.2
3+ 
consultations
18.1 15.5 17.3 15.5 12.8 14.7
At	least	one	alarm	symptom	(anaemia,	rectal	bleeding,	change	in	bowel	habits)
2–12	months	
pre‐diagnosis
37.7 20.1 31.8 <0.001 34.5 14.5 28.6 <0.001 0.002 0.009
12–23	months 7.4 8.3 7.7 0.413 5.3 5.3 5.3 0.960 0.010 <0.001
24–36	months 4.5 5.3 4.8 0.316 3.1 4.4 3.5 0.102 0.336 0.017
Specific	symptoms
Change in bowel habit
New onset 6.7 2.0 5.1 <0.001 7.0 2.4 5.6 <0.001 0.675 0.347
Chronic 0.1 0.1 0.1 0.1 0.1 0.1
Past 1.6 1.5 1.6 1.2 0.9 1.1
Rectal bleeding
New onset 10.1 3.3 7.8 <0.001 10.3 2.9 8.1 <0.001 0.427 0.940
Chronic 1.2 0.7 1.0 1.1 0.5 0.9
Past 3.2 3.2 3.2 3.5 2.2 3.1
Anaemia
New onset 17.5 11.7 15.6 <0.001 15.8 7.7 13.4 <0.001 <0.001 <0.001
Chronic 4.1 3.4 3.9 2.5 2.0 2.3
Past 4.6 7.8 5.7 3.4 5.4 4.0
Abdominal	pain
New onset 15.1 16.6 15.6 0.781 14.7 14.3 14.6 0.987 0.024 <0.001
Chronic 6.8 6.7 6.8 4.2 4.4 4.2
Past 10.4 10.0 10.3 8.5 8.6 8.5
Constipation
New onset 5.6 6.2 5.8 0.023 4.9 5.8 5.2 0.060 0.021 0.014
Chronic 1.6 3.3 2.1 1.5 1.1 1.4
Past 6.6 6.6 6.6 4.6 6.8 5.3
Diarrhoea
New onset 6.0 6.8 6.3 0.390 6.0 6.0 6.0 0.942 0.028 <0.001
Chronic 2.5 1.6 2.2 0.9 1.0 0.9
Past 8.5 8.9 8.6 5.3 5.7 5.4
Fatigue
New onset 3.9 3.4 3.7 0.160 3.2 3.1 3.2 0.596 <0.001 <0.001
Chronic 1.8 0.9 1.5 0.7 0.3 0.6
Past 7.8 8.8 8.2 4.8 4.1 4.6
(Continues)
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(Figure	2).	No	such	association	was	observed	for	past/chronic	benign	
diagnoses and no association was apparent between benign diagno‐
ses and emergency presentations in men. Results were similar when 
analysing	 each	 cancer	 sub‐site	 and	 gender	 separately	 (Supporting	
Information	Appendix	Tables	S1–S2),	but	without	reaching	statistical	
significance due to sparse data in stratified analyses.
3.5 | Benign diagnoses and effect on emergency 
presentations among women stratified by age
The prevalence of a benign diagnosis among women with colon 
cancer diagnosed as emergencies was particularly high among 
40–49‐year‐olds	(18.4%),	while	it	was	8.8%	in	50–59‐year‐olds	and	
lower	in	all	other	age	groups	(4.5%–6.8%;	data	not	shown	in	table).	
Concordantly,	there	was	statistical	evidence	of	effect	modification	
for a recent benign diagnosis on the risk of emergency presentation 
by	age	(likelihood	ratio	test	p	=	0.013).
Multivariable logistic regression stratified by age and controlling 
for	deprivation,	cancer	sub‐site	and	symptoms	highlighted	how	the	
risk	of	emergency	presentation	was	particularly	high	for	40–59‐year‐
old women with a recent benign diagnosis compared to those with‐
out	a	benign	diagnosis	(OR	=	4.41;	95%	CI	1.3–14.9).	There	was	no	
significant	effect	of	a	benign	diagnosis	on	all	other	groups	(Table	4).
4  | DISCUSSION
4.1 | Main findings
The study provides population‐based evidence on factors associated 
with	 emergency	 colon	 cancer	 diagnosis	 in	women	 and	men,	 high‐
lighting possible opportunities for earlier diagnosis. Consultation 
rates with relevant symptom pre‐cancer diagnosis were higher in 
women than men and increased substantially in the pre‐diagnos‐
tic year; the increase in relevant consultations occurred earlier in 
women	with	proximal	colon	cancer,	who	were	also	at	increased	risk	
of emergency diagnosis. Women with abdominal symptoms in the 
pre‐diagnostic year were twice as likely to be diagnosed with a be‐
nign	 condition	 (IBS	or	 diverticular	 disease)	 compared	 to	men	with	
Women Men
Women  
vs. Men 
EP only
Women  vs. 
Men total 
sample
Non‐EP 
(%) EP (%) Total (%)
p‐
Valuea
Non‐EP (%) EP (%) Total (%)
p‐
Valuea p‐Valueb p‐ValuecN = 1859 N = 940 N = 2,799 N = 2072 N = 874 N = 2,946
Weight loss
New onset 1.9 2.0 2.0 0.962 2.5 2.9 2.6 0.796 0.574 0.061
Chronic 0.1 0.1 0.1 0.2 0.1 0.2
Past 2.0 2.1 2.1 1.3 1.6 1.4
Benign	GI	diagnosis	recorded	between	2–12	months	pre‐diagnosis
IBS	or	Diverticular	diseased
New onset 5.1 6.0 5.4 0.678 3.4 2.3 3.1 0.258 0.000 0.000
Chronic 0.8 0.9 0.8 0.5 0.2 0.4
Past 4.6 5.2 4.8 2.1 2.3 2.2
Haemorrhoids
New onset 2.0 0.7 1.6 0.013 2.0 1.1 1.8 0.344 0.421 0.905
Chronic 0.5 0.2 0.4 0.5 0.3 0.5
Past 3.2 2.0 2.8 2.8 3.0 2.8
3+	Pre‐referral	consultations	for	relevant	symptoms	pre‐diagnosis	(only	patients	with	referral:	687	women	and	674	men)
14.2 21.7 15.6 0.033 12.7 21.0 14.0 0.027 0.897 0.397
Comorbidities	recorded	in	HES	between	0–24	months	pre‐diagnosis
0 77.6 63.3 72.8 <0.001 74.5 58.1 69.6 <0.001 0.038 0.003
1–2 19.4 30.0 22.9 20.8 32.7 24.3
3+ 3.1 6.7 4.3 4.7 9.2 6.0
Notes. New onset: symptom recorded for the first time during the pre‐diagnostic year with no prior record of the same symptom; Chronic: recorded 
both	during	the	pre‐diagnostic	year	and	in	previous	years;	Past:	recorded	only	in	the	past	2–5	years,	with	no	record	in	the	pre‐diagnostic	year.
aChi‐square	test	comparing	EP	vs.	non‐EP.	bChi‐square	test	comparing	women	EP	vs.	men	EP.	cChi‐square	test	comparing	women	vs.	men	overall	(in‐
cluding	EP	and	non‐EP).	dIrritable	bowel	syndrome	(IBS)	and	diverticular	disease	were	grouped	together	due	to	sparse	data	(diverticular	disease	n = 183 
and	IBS	n	=	98).	
TA B L E  2   (Continued)
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similar	symptoms.	A	new‐onset	benign	condition	and	a	past	history	
of	anaemia	2–5	years	pre‐diagnosis	were	associated	with	emergency	
presentations	in	women,	but	not	in	men.	A	particularly	high	risk	of	
emergency	presentations	was	observed	among	women	aged	40–59	
TA B L E  3  Mixed‐effects	logistic	regression	Odds	Ratios	(OR)	for	
colon	cancers	diagnosed	after	Emergency	Presentation	(EP)	vs.	
non‐EP,	taking	socio‐demographic	characteristics,	GP	consultations	
and	clinical	history	into	account	(N	=	5,745)
Adjusted ORs for both genders
OR 95% CI p‐Value
Gender
Men 1
Women 1.20 1.06 1.35 0.005
Age	(years)
18–59 1.83 1.50 2.24 <0.001
60–69 1
70–79 1.32 1.11 1.57 0.002
80+ 2.23 1.87 2.67 <0.001
SES	(deprivation	quintile)
1	(least	deprived#) 1
2 1.17 0.98 1.40 0.091
3 1.03 0.86 1.24 0.758
4 1.14 0.94 1.37 0.186
5	(most	deprived) 1.39 1.13 1.72 0.002
Year of diagnosis
2005–2006 1
2007–2008 0.79 0.68 0.92 0.002
2009–2010 0.78 0.67 0.90 0.001
Cancer sub‐site
Colon	proximal 1
Colon distal 0.93 0.82 1.07 0.323
Colon unspecified 1.28 1.05 1.56 0.016
No. visits during 
2–12	months	
pre‐diagnosis
0.99 0.98 0.99 <0.001
Change in bowel habit
Never 1
New onset 0.30 0.21 0.43 <0.001
Chronic/past 0.70 0.41 1.19 0.184
Rectal bleeding
Never 1
New onset 0.26 0.19 0.35 <0.001
Chronic/past 0.62 0.45 0.87 0.005
Anaemia
Never 1
Chronic 0.60 0.41 0.87 0.007
New onset 0.44 0.36 0.53 <0.001
Past 1.20 0.91 1.58 0.201
Abdominal	pain
Never 1
Chronic 0.98 0.73 1.31 0.880
New onset 0.99 0.82 1.19 0.914
(Continues)
Adjusted ORs for both genders
OR 95% CI p‐Value
Past 1.06 0.85 1.32 0.604
Constipation
Never 1
Chronic 1.40 0.89 2.20 0.145
New onset 1.13 0.86 1.48 0.392
Past 1.13 0.87 1.47 0.352
Diarrhoea
Never 1
Chronic 0.78 0.47 1.32 0.361
New onset 1.04 0.81 1.35 0.743
Past 1.01 0.79 1.29 0.928
Fatigue
Never 1
Chronic 0.43 0.21 0.86 0.017
New onset 0.92 0.66 1.29 0.632
Past 0.95 0.73 1.22 0.668
Weight loss
Never 1
New onset 1.01 0.68 1.50 0.954
Chronic/past 1.10 0.69 1.74 0.695
IBS	or	Diverticular	disease
Never 1
New onset 1.06 0.78 1.45 0.696
Chronic/past 1.19 0.87 1.63 0.278
Haemorrhoids
Never 1
New onset 0.49 0.27 0.90 0.022
Chronic/past 0.84 0.58 1.22 0.361
3+	Pre‐referral	consultations	with	relevant	symptoms	2–12	months	
pre‐diagnosis
0–2 1
3+ 1.25 1.06 1.56 0.048
Comorbidities	recorded	in	HES	between	0–24	months	pre‐diagnosis
0 1
1+ 2.15 1.87 2.48 <0.001
Notes. New onset: symptom recorded for the first time during the pre‐di‐
agnostic year with no prior record of the same symptom; Chronic: re‐
corded both during the pre‐diagnostic year and in previous years; Past: 
recorded	only	in	the	past	2–5	years,	with	no	record	in	the	pre‐diagnostic	
year.
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with	a	new‐onset	benign	diagnosis,	highlighting	the	need	for	innova‐
tive diagnostic strategies for this patient group. These may include 
use	of	quantitative	faecal	haemoglobin	testing	 (FIT)	or	other	colo‐
rectal cancer investigations.
4.2 | Comparison with previous literature
IBS,	affecting	about	8%	of	the	general	population	in	Western	coun‐
tries	and	occurring	more	frequently	in	women	(Lovell	&	Ford,	2012;	
Sperber	et	al.,	2017)	can	present	with	abdominal	pain,	altered	bowel	
habit and bloating in the absence of detectable organic disease. 
According	 to	 guidelines,	 the	 diagnosis	 is	 based	 on	 clinical	 criteria	
(Rome	IV	criteria)	without	the	need	for	extensive	 investigations	to	
exclude	other	conditions	(Canavan	et	al.,	2014;	Ford,	Lacy,	&	Talley,	
2017;	Mearin	 et	 al.,	 2016;	Moayyedi	 et	 al.,	 2017;	NICE	guidelines	
[NG12];	Spiegel,	Farid,	Esrailian,	Talley,	&	Chang,	2010),	as	the	diag‐
nostic	yield	is	low	in	the	absence	of	alarm	signs/symptoms	(Chey	et	
al.,	2010).	IBS	does	not	increase	the	risk	of	colon	cancer	overall,	with	
IBS	patients	having	similar	cancer	incidence	as	the	general	popula‐
tion	 (Canavan	et	al.,	2014;	Norgaard	et	al.,	2011).	However,	 in	 the	
first	6	months	after	an	IBS	diagnosis	colorectal	cancer	incidence	is	
4–41	times	higher	than	in	controls	 (Canavan	et	al.,	2014),	with	pa‐
tients younger than 50 having the highest risk. This might be due 
to	symptoms	being	initially	attributed	to	the	benign	diagnosis,	while	
subsequent	investigations	revealed	the	underlying	cancer.	Contrary	
to	 guidelines,	 many	 gastroenterologists	 and	 primary	 care	 doctors	
believe	IBS	is	a	diagnosis	of	exclusion	and	refer	patient	for	tests	to	
exclude	serious	organic	conditions	(Spiegel	et	al.,	2010).	Spiegel	et	
al.	(2010)	also	highlighted	that	often	doctors	make	an	“internal	diag‐
nosis”	when	visiting	patients,	without	being	willing	to	“externalise”	
the diagnosis to the patient; less than half of doctors were willing to 
communicate the diagnosis without first performing additional test‐
ing.	This	suggests	that	the	relatively	low	IBS	prevalence	in	our	study	
is	an	underestimation	of	cases	where	the	doctor	made	an	“internal	
diagnosis.”
Similar	to	IBS,	diverticular	disease	is	a	chronic	disorder	which	
often	presents	with	recurrent	abdominal	symptoms	(Strate	et	al.,	
2012).	While	not	increasing	the	risk	of	colon	cancer	overall,	during	
the first year of a diverticular disease diagnosis there is a strong 
association	with	 colon	 cancer,	 probably	 due	 to	misclassification	
and	difficulties	with	differential	diagnosis	(Regula,	2016).	Both	IBS	
and	diverticular	disease	might	provide	“alternative	explanations”	
to	 cancer.	 This	 is	 in	 line	with	 a	 study	 (Mounce,	 Price,	 Valderas,	
&	Hamilton,	2017)	 reporting	how	comorbidities	providing	“alter‐
native”	explanations	 (including	 IBS	and	diverticular	diseases)	are	
associated with longer diagnostic intervals for colorectal cancer. 
Our	study	shows	that	for	patients	with	an	underlying	colon	can‐
cer,	receiving	an	IBS	or	diverticular	disease	diagnosis	can	be	asso‐
ciated with an increased risk of emergency presentation. Patients 
might	feel	over‐reassured	or	under‐supported	(Renzi,	Whitaker	et	
al.,	2016)	after	a	benign	diagnosis	and	thus	not	return	to	their	doc‐
tor	even	if	symptoms	worsen,	or	there	might	be	delays	in	referrals	
for investigations.
Further	 work	 is	 necessary	 to	 examine	 these	 possible	 mecha‐
nisms,	 as	 well	 as	 examining	 whether	 benign	 diagnoses	 were	 sup‐
ported	by	previous	investigations.	Using	data	from	electronic	health	
records	 (as	 in	 our	 study)	 can	 reveal	 patient	 groups	 at	 greater	 risk	
of	emergency	presentation,	there	remain	however	questions	about	
the	exact	circumstances	that	could	allow	for	such	presentations	to	
be	prevented.	In	that	respect,	qualitative	record	review	studies	can	
be	very	important.	For	example,	in	a	study	reviewing	the	clinical	re‐
cords	of	Scottish	patients	(Murchie	et	al.,	2017)	30%	of	emergency	
presenters	previously	seen	by	their	GP	with	relevant	symptoms	had	
an emergency diagnosis while awaiting a secondary care appoint‐
ment;	 19%	 experienced	 a	 genuine	 missed	 opportunity	 for	 earlier	
investigation	(with	missed	opportunities	occurring	more	frequently	
in	women	than	men);	while	only	a	small	minority	of	patients	had	re‐
fused or did not attend follow‐up appointments or investigations. 
Similar	approaches	have	also	been	employed	in	US	healthcare	set‐
tings	 (Singh	 et	 al.,	 2009).	Complementing	 such	 detailed	 case	 note	
reviews with population‐based epidemiological studies like ours is 
important to provide a more comprehensive picture and inform the 
development of strategies for reducing emergency presentation 
at	 population	 level.	 By	 identifying	 subgroups	 of	 the	 population	 at	
higher	 risk,	epidemiological	 studies	can	also	help	priorities	 further	
in‐depth case note review studies.
In	our	study	we	have	shown	that	multiple	pre‐referral	consulta‐
tions	were	associated	with	emergency	presentations,	indicating	how	
generally prompt specialist referrals can reduce emergency diagno‐
ses.	Women	are	known	to	have	more	frequent	consultations	(Abel	et	
al.,	2017;	Hansen	et	al.,	2015),	longer	diagnostic	intervals	(Din	et	al.,	
2015)	and	higher	risk	of	three	or	more	consultations	before	special‐
ist	referrals,	particularly	in	the	context	of	urinary	tract	cancer	(Cohn,	
Vekhter,	 Lyttle,	 Steinberg,	 &	 Large,	 2014;	 Lyratzopoulos,	 Abel,	
McPhail,	Neal,	&	Rubin,	2013).	 It	has	been	suggested	 that	general	
practitioners	interpret	symptoms,	such	as	haematuria,	differently	in	
women	compared	to	men,	with	possible	misattribution	of	symptoms	
to	benign	causes,	early	in	the	diagnostic	process	(Cohn	et	al.,	2014;	
Lyratzopoulos	 et	 al.,	 2013).	 This	might	 be	 a	 consequence	 of	 posi‐
tive predictive values of various possible cancer symptoms being 
lower	in	women	than	in	men	(Hamilton	et	al.,	2009;	Jones,	Latinovic,	
Charlton,	&	Gulliford,	2007).	Differential	diagnosis	in	women	can	be	
particularly complicated as recurrent abdominal pain and/or anae‐
mia can sometimes be related to gynaecological conditions with a 
risk	of	over‐reassurance	or	false	reassurance.	Specifically	designed	
quantitative	 and	 qualitative	 studies	 would	 be	 needed	 to	 explore	
these	 issues	 further.	A	 greater	 understanding	of	 the	 interplay	 be‐
tween	gender,	age,	benign	diagnoses,	chronic	morbidities	and	symp‐
tomatic presentations is necessary in order to optimise diagnostic 
approaches	and	guidelines	for	higher	risk	groups.	For	example,	new‐
onset	IBS	in	middle‐aged	women	is	an	indication	for	CA125	testing	
according	 to	 NICE	 guidelines	 (NICE	 guidelines	 [NG12]),	 yet	 new‐
onset	IBS	is	not	currently	considered	a	clear	indication	for	quantita‐
tive	faecal	haemoglobin	testing	(FIT).
Anaemia	 is	 a	well‐known	 symptom	associated	with	 colon	 can‐
cer	 (Hamilton	 et	 al.,	 2009)	 and	 our	 findings	 have	 highlighted	 that	
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F I G U R E  2  Odds	Ratios	for	women	and	men	diagnosed	with	proximal	or	distal	colon	cancer	after	Emergency	Presentation	(EP)	compared	
to	non‐EP.	Note:	Multinomial	logistic	regression	taking	socio‐demographic	characteristics,	GP	consultations	and	clinical	history	into	account
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while	new‐onset	alarm	symptoms,	including	new‐onset	anaemia,	de‐
creased	the	risk	of	emergency	presentation,	a	long‐standing	history	
of anaemia in women can lead to emergency presentations. Previous 
research	also	suggested	that	anaemia	was	a	frequent	missed	diag‐
nostic	opportunity	in	colorectal	cancer	(Singh	et	al.,	2009).
4.3 | Limitations
The study does not reflect the prevalence of symptoms and benign 
diagnoses	 in	 the	general	 population,	 nor	does	 it	 aim	 to	evaluate	
the predictive value of symptoms comparing cancer patients with 
the	general	 population,	 as	performed	 in	other	 studies	 (Hamilton	
et	al.,	2009).	Rather,	our	study	focused	on	identifying	factors	as‐
sociated with emergency presentations and opportunities for 
preventing them among cancer patients. We relied on clinical re‐
cords of symptoms/signs which do not necessarily represent all 
symptoms	experienced	by	patients.	Despite	the	 likely	underesti‐
mation	of	sign/symptoms	and	diagnoses	(Price,	Stapley,	Shephard,	
Barraclough,	 &	 Hamilton,	 2016),	 we	 have	 no	 reason	 to	 expect	
differential	recording	by	emergency	presentation	status,	as	infor‐
mation was prospectively recorded during the months and years 
before the cancer diagnosis.
The	 clinical	 management	 of	 patients	 with	 anaemia	 2–5	years	
pre‐diagnosis	merits	further	examination.	Danish	studies	showed	an	
increase	in	prescriptions	prior	to	a	colon	cancer	diagnosis	(Pottegard	
&	Hallas,	2017).	Similar	to	our	findings,	this	suggests	that	symptoms	
are	attributed	to	benign	diagnoses	in	some	patients.	Further	work	is	
needed	exploring	the	effect	of	gynaecological	and	other	coexisting	
conditions on the risk of delayed cancer diagnosis and emergency 
presentations.
Our	 study	 will	 need	 to	 be	 extended	 to	 more	 recent	 years.	
However,	even	though	emergency	presentations	for	colorectal	can‐
cer	have	decreased	in	England	between	2006	and	2010	(from	27%	
to	23%),	they	have	remained	around	23%	since	2010	(NCIN).	Specific	
data	 for	 colon	 cancer	 is	 limited	 to	 2006–2010	 (31%	diagnosed	 as	
an	emergency;	Abel	et	al.,	2015).	 It	 is	noteworthy	that	 inequalities	
in	emergency	presentations	 (Abel	et	al.,	2015)	and	cancer	survival	
(Ellis,	Coleman,	&	Rachet,	2012)	are	still	relevant.
4.4 | Implications for research and practice
Our	population‐based	study	suggests	 that	 there	are	opportunities	
for earlier colon cancer diagnosis and for reducing emergency pres‐
entations in some patients. The findings are unlikely to be simply 
explained	by	poor	clinical	practice	of	some	doctors,	considering	that	
we	analysed	prospectively	collected	data	from	343	GP	practices	in	
England	(average	of	3	colon	cancers	per	practice/year),	taking	pos‐
sible	 clustering	 by	 practice	 into	 account.	 Further	 quantitative	 and	
qualitative	 studies	 are	 needed	 in	 order	 to	 gain	 additional	 insights	
into	the	doctor–patient	interactions	preceding	the	emergency	can‐
cer	diagnoses	and	the	clinical	management	of	symptomatic	patients,	
including	an	analysis	of	prescriptions,	referrals	and	type	and	timing	
of investigations performed before an emergency cancer diagnosis. 
Considering	that	emergency	presentations	occur	due	to	a	complex	
interplay	 between	 patient,	 cancer	 and	 healthcare‐related	 factors	
(Holme	et	al.,	2017;	Lyratzopoulos,	Wardle,	&	Rubin,	2014;	Murchie	
et	al.,	2017;	Zhou	et	al.,	2017),	multifaceted	system‐wide	approaches	
are	probably	needed,	together	with	innovations	in	diagnostic	tech‐
nology and optimising screening. The majority of colorectal can‐
cers	 are	 diagnosed	 after	 symptoms	 have	 developed	 (Goodyear	 et	
al.,	 2008),	 thus	 earlier	 diagnosis	 in	 symptomatic	 patients	 remains	
crucial.	Attention	 is	needed	not	only	for	people	with	typical	alarm	
symptoms,	but	also	for	those	repeatedly	presenting	with	lower	risk	
symptoms,	especially	in	the	case	of	women.	Organizational	innova‐
tions in primary care can help improve the diagnosis and manage‐
ment	 of	 complex	 cases	 (BMA,	 2016;	 Hobbs	 et	 al.,	 2016;	 Rimmer,	
2017).	 Greater	 integration	 with	 specialists	 and	 multi‐disciplinary	
diagnostic	 centres	 (Independent	Cancer	Taskforce,	 2015)	 can	 also	
facilitate early diagnosis.
Specific	 attention	 is	 warranted	 for	 women	 aged	 40–59	years	
with	 a	 recent	 diagnosis	 of	 IBS	 or	 diverticular	 disease,	 as	 this	 age	
group	 is	 characterised	 by	 an	 increase	 in	 colon	 cancer	 incidence,	
paralleled	 by	 a	 decrease	 in	 new	 IBS	 onset.	 It	 is	 noteworthy	 that	
for	women	 aged	 50	 and	 over	who	 have	 been	 diagnosed	with	 IBS	
for	the	first	time	in	the	last	year,	NICE	guidelines	in	the	UK	recom‐
mend	 investigations	 for	ovarian	cancer,	 as	 IBS	 rarely	 starts	at	 this	
age	(NICE	guidelines	[NG12]),	while	no	specific	recommendation	is	
made	regarding	the	possibility	of	colon	cancer	in	these	patients,	un‐
less	typical	alarm	symptoms	are	present.	According	to	international	
experts,	 a	 colonoscopy	 is	 indicated	 for	 all	 patients	 aged	 50	years	
and	over	with	symptoms	such	as	diarrhoea	and	mixed	bowel	habit	
(Ford	et	al.,	2017;	Moayyedi	et	al.,	2017).	Relatedly,	 the	American	
Gastroenterology	 Association	 recently	 recommended	 excluding	
colon	 cancer	 with	 modern	 techniques	 and	 colonoscopy	 after	 the	
first	episode	of	diverticulitis	(Regula,	2016).
Our	 findings	 suggest	 that	women	 aged	 40–59	with	 symptoms	
compatible	 with	 a	 recent	 onset	 IBS	 or	 diverticular	 disease	 are	 at	
increased risk of emergency diagnosis and appropriate strategies 
will	need	to	be	developed	to	address	this.	In	addition	to	safety	net‐
ting	 and	 specialist	 advice,	 quantitative	 FIT	 could	 be	 considered.	
According	 to	 recent	 research	 (Hogberg,	 Karling,	 Rutegard,	&	 Lilja,	
2017;	 Mowat	 et	 al.,	 2016)	 and	 NICE	 guidelines	 (NICE	 guidelines	
TA B L E  4  Odds	Ratios	(OR)	for	the	association	between	a	recent	
benign	diagnosis	(IBS/diverticular	disease)	and	emergency	
presentations	among	women	only,	stratified	by	age
Adjusted ORs for women only
OR 95% CI p‐Value
Age	(years)
40–59 4.41 1.3 14.9 0.017
60–69 1.43 0.6 3.7 0.464
70+ 1.29 0.8 2.1 0.322
Mixed	effects	binary	logistic	regression	ORs	estimated	in	separate	mod‐
els	for	each	age	group,	controlling	for	sociodemographic	factors,	cancer	
sub‐site and symptoms.
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[NG12]),	quantitative	FIT	can	be	useful	for	patients	presenting	with	
abdominal symptoms in primary care in order to identify those who 
might benefit from further investigations.
With one in three colon cancers diagnosed as an emergency and 
considering that 12‐month survival for patients with an emergency 
colorectal	cancer	diagnosis	is	51%,	compared	to	more	than	80%	for	
non‐emergency	routes	(NCIN),	it	is	important	to	develop	innovative	
diagnostic strategies. Reducing emergency presentations and ad‐
dressing	inequalities	will	help	to	improve	patient	experience,	quality	
of care and cancer survival.
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